Skip to main content

The Alzheimer’s Drug Discovery Summit

The Alzheimer’s Drug Discovery Summit

The Alzheimer’s Drug Discovery Summit is specifically designed for GPs, nurses, and community carers, providing you with the latest advancements in research, treatment options, and practical tools to guide and support your patients confidently.  

Gain valuable insights on emerging drug discoveries, understand the nuances of clinical trials, and learn how to navigate challenging conversations with empathy and expertise. Discover innovative care strategies, explore the power of early detection, and connect with fellow professionals to share best practices and build a stronger support network. The Alzheimer's Drug Discovery Summit equips you with the knowledge and resources to make a real difference to the lives of those affected by Alzheimer's, empowering them to face the future with hope and understanding. 

Book Tickets

Who attends?

Who attends?

  • GP’s
  • Neurologists
  • Geriatricians
  • Psychiatrists
  • Neuropsychologists
  • Nurses including Research Nurses
  • Research Coordinators
  • Clinical Trial Researchers
  • Pharmaceutical Scientists
  • Academic Researchers
  • Professional Carers
  • Community Care Professionals

 

The Alzheimer’s Drug Discovery Summit Programme

Friday 14th June

10:00 Chair’s welcome remarks 

10.10 Keynote Address: Unveiling Hope in Alzheimer's Research 

  • Where are we now? Determining the current status of Alzheimer’s drug development. 

  • Exploring promising research avenues like personalized medicine and new drug targets. 

  • Highlighting the importance of ongoing research, collaboration, and staying updated in the fight against Alzheimer's. 

  • Emphasizing the potential for future breakthroughs and a continued commitment to finding a cure. 

10.40 A GP Panel: Navigating Challenges When Discussing Treatment Options for Alzheimer's 

This GP panel explores the challenges and potential solutions for effectively communicating with Alzheimer's patients and families about treatment options. Key points discussed included: 

  • Managing expectations and balancing hope for future advancements with the current limitations of treatment. 

  • Differentiating promising research from established treatment options. 

  • Addressing emotional complexities and creating a safe space for patients and families to express concerns and fostering empathy. 

  • Empowering patients and families in shared decision-making and providing access to resources and support groups. 

11.20 Networking Break 

11.40 Presentation reserved for Gold Sponsor TauRx 

12.10 Panel discussion: The significance of early Alzheimer's diagnosis in improving patient outcomes and quality of life. 

  • Moderated by a healthcare professional/researcher experienced in diagnosis 

  • Innovative Diagnostic Technologies and Biomarkers e.g. Blood BioMarker Challenge 

  • Impact of Early Diagnosis on Treatment Efficacy and Disease Progression  

  • Future Directions and Opportunities in Early Alzheimer's Diagnosis Research  

  • Q&A session for audience enquiries 

13.00 Lunch and Networking 

14.00 Presentation reserved for Gold Sponsor Eisai 

14.30 Emer MacSweeney – Re:Cognition Health 

15.00 Potential issues and challenges in evaluation of disease-modifying dementia treatments. Fatima Salih, Scientific Adviser in the Science Policy and Research Programme. NICE 

15.30 Coffee Break and Networking 

15.50 Presentation reserved for Gold Sponsor 

16.20 Panel Discussion: Demystifying Clinical Trials - How You Can Inform Your Patients 

  • Understanding the different types of clinical trials and their role in drug development 

  • Ethical considerations surrounding clinical trial participation 

  • Supporting patients' informed decision-making about clinical trial participation 

17.00 Close of Summit 

What to expect?

For over 10 years The Alzheimer’s and Dementia Show has been the UK’s largest event which professional and family carers attend to hear about the latest advancements in the field, to receive training and to assess products and services that will benefit those they care for.

The Alzheimer’s Drug Discovery Summit is a single day professional-only conference within The Alzheimer’s and Dementia Show, specifically for primary and community care professionals who need the latest information to share with the patient population. Network with 200 of your peers in a professional collaborative environment as we target new frontiers in Alzheimer’s drug discovery and development. Plus, Gain 7 CPD points from attending the Summit.